Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
07/2003
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/03/2003CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003CA2471038A1 Process for the preparation of perfluoroalkanesulfonic acid esters and salts thereof
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2468831A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1323710A1 Nitrogenous five-membered ring compounds
07/02/2003EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322609A2 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
07/02/2003EP1322608A1 Delta1-pyrrolines used as pesticides
07/02/2003EP1322607A1 Optically active 2,5-bisaryl-delta1-pyrrolines and their use as pest control agents
07/02/2003EP1322606A1 Method for producing delta 1 -pyrrolines
07/02/2003EP1322605A1 Method for producing delta 1-pyrrolines
07/02/2003EP1322604A1 Delta 1-pyrrolines for use as pesticides
07/02/2003EP1322602A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322597A1 Process and intermediates
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003EP1322587A1 Method for producing ketocarboxylic acid derivatives
07/02/2003EP1322309A2 High affinity small molecule c5a receptor modulators
07/02/2003EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
07/02/2003EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases
07/02/2003EP0991627B1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
07/02/2003EP0913392B1 Ethylene derivatives and pest controlling agents
07/02/2003CN1427823A Pyrrolecarboxamides and pyrrolethioamides as fungicides
07/02/2003CN1427821A Method for producing cyclic lactams
07/02/2003CN1427719A Use of substituted acryloyl distamycin derivatives in treatment of tumors associated with high levels of glutathione
07/02/2003CN1113064C Cis-substituted aminocyclopropane derivatives
07/01/2003US6586627 N-protected/N-substituted-beta-amino hydroxy sulfonates
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
07/01/2003US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders
07/01/2003US6586418 Heteroaryl-phenyl substituted compounds that are inhibitors of trypsin-like serine protease enzymes; anticoagulant for treatment and prevention of thromboembolic disorders
07/01/2003US6586369 Fungicidal agents containing pyrrolidones as their active agents and use thereof for treating plants
06/2003
06/26/2003WO2003052106A1 Method of screening compounds
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists
06/26/2003WO2003051836A1 Prodrugs to d-prolines
06/26/2003WO2003051825A1 Human adam-10 inhibitors
06/26/2003WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003WO2003051814A1 Synthesis of pyrroles
06/26/2003WO2003051813A1 Methods of making intermediates from polyhydroxyalkanoates
06/26/2003WO2003051276A2 Therapeutic heterocycles
06/26/2003WO2003002491A3 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
06/26/2003US20030120087 Catalytically hydrogenating n-methyl-succinimide to form n-methylpyrrolidone
06/26/2003US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants
06/26/2003US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction
06/26/2003US20030120034 N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(N-meth yl acetamido)-5-(methylcarbamyl)benzamidoacetamido)-isophthalmic acid, derivatives
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119891 Polylactam oligomers of N-methyl-2-carboxy-4-imidazole, N-methyl-2-carboxy-4-aminopyrrole modified by 4-aminobutyric acid, 3-amino-propionic acid and 3-(dimethylamino)propylamine binding specifically to the cyclogenase 2 gene
06/26/2003US20030119874 Method for enhancing mutant enzyme activity in gaucher disease
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke.
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119751 Peptidomimetic; N-aminobutyl-N'-nitroguanidine derivatives
06/26/2003US20030119750 Use of dipeptidyl peptidase IV inhibitors
06/26/2003US20030119749 Novel compounds possessing antibacterial, antifungal or antitumor activity
06/26/2003US20030118627 Glyceraldehyde 3 phosphate dehydrogenase enzyme inhibitors
06/26/2003CA2473938A1 Human adam-10 inhibitors
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2470311A1 Method of screening compounds
06/26/2003CA2468978A1 Therapeutic heterocycles
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1321462A1 Method of purifying 4-hydroxy-2-pyrrolidione
06/25/2003EP1321461A1 N-(Cyclopropylmethyl)-azacycloalkanes, compositions containing them and methods for their preparation
06/25/2003EP1321454A1 Process for the removal of nitrobenzenesulfonyl
06/25/2003EP1321452A2 Process for the preparation of optically active amines or salts thereof
06/25/2003EP1320538A2 Process for the preparation of 5-phenylpentanoyl-ala-argl-ala- 2-[3-amino-2-oxopyrrolidin-1-yl]propionyl - ala-arg-ala-4-aminophenylacetamide
06/25/2003EP1320532A1 Tetrapyrroles
06/25/2003EP1320526A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
06/25/2003EP1320525A1 Antibacterial mutilins
06/25/2003EP1320522A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/25/2003EP0966282B1 Use of the angiotensin ii antagonists losartan and exp-3174 to treat symptomatic heart failure
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003EP0777652B1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583297 Process and intermediate compounds for the preparation of pyrrolidines
06/24/2003US6583296 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and α-1-blocking action
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583158 Method for enhancing mutant enzyme activities in lysosomal storage disorders
06/24/2003US6582928 Carbohydrate-directed cross-linking reagents
06/24/2003CA2272014C N-aryl/heteroaryl-substituted heterocycles
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/21/2003CA2414905A1 N-(cyclopropylmethyl)azacycloalkanes, compositions containing them and methods of preparation
06/19/2003WO2003050085A1 CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-HEPTANOIC ACID CALCIUM SALT (2:1)
06/19/2003US20030114687 By hydrogenation of starting materials including succinic acid, N-methylsuccinimide; efficiency
06/19/2003US20030114686 Crystalline forms of atorvastatin
06/19/2003US20030114685 Processes for preparing calcium salt forms of statins
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114490 New phenylalanine derivatives
06/19/2003US20030114489 Asthma therapy; antiallergens; antiinflammatory agents
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 404